PPA
Quick Facts
Approved Uses
Nasal decongestant
Appetite suppressant
Manufacturers
Bayer
Novartis
Wyeth
Bayer
Schering-Plough
Status
Removed 2000
Drugs With PPA
Alka-Seltzer Plus
Contac
Dexatrim
Tavist-D
BC Cold Powder
12-Hour Cold Capsules
Dimetapp
Serious Side Effects
Stroke
Death
Seizures
Cerebral hemorrhages
Related Topics
Stroke
Defective Drugs
Diseases
CLICK HERE TO DOWNLOAD OUR INFORMATION PACKAGE
PPA Side Effects Could Lead To Stroke Lawsuits
PPA | Lawsuits, Lawyers | Side Effects: Hemorrhagic Strokes, Bleeding In Brain
Phenylpropanolamine (PPA) has been linked to dangerous side effects that cause hemorrhagic strokes. PPA is a chemical that was the active ingredient in numerous over the counter and prescription diet drugs, nasal decongestants and cough medications such as Dexatrim, Acutrim, Robitussin, Comtrex, Triaminic, and Tavist D. In 1990, U.S. consumers bought about 6 billion doses of medication that contained PPA.
In November 2000, U.S. regulators first moved to take Phenylpropanolamine off the market due to the serious side effects. The Food and Drug Administration said it has asked all drug companies to voluntarily stop marketing products containing PPA and is seeking to make the sale of PPA products, both prescription and over-the-counter, illegal. While research pointed to a higher risk of hemorrhagic strokes, or bleeding into the brain, for women, the FDA cautioned that men were also at risk. The strokes occurred within three days after people took the products.
Legal Help For Victims Affected By PPA
If you or a loved one took a product containing Phenylpropanolamine (PPA) and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects lawyers or call us at 1-800LAW-INFO (1-800-529-4636).










